Poltreg is under certification of its new plant. Today is a big day – we released successfully first GMP-
compliant Tregs cellular product from the unit 1. Everything is up and running for routine
manufacturing. Congratulation to the team!
In the facility we can manufacture around 1500 products yearly – all we need for our ongoing trials
and commercial hospital-exemption activities. There is also a space to our antigen-specific, CAR and
TCR-engineered Tregs and CDMO work. R&D labs, where we work on new ideas and products, are
also located in the facility.